Abstract P4-22-08: A single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer

Mapping Intimacies ◽

10.1158/1538-7445.sabcs16-p4-22-08 ◽

2017 ◽

Cited By ~ 2

Author(s):

I Krop ◽

J Cortes ◽

K Miller ◽

MT Huizing ◽

L Provencher ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Clinical Activity ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 2 Study

Download Full-text

A phase 2 single-arm study to assess clinical activity, efficacy and safety of enzalutamide (ENZA) with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps640 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS640-TPS640

Author(s):

Maureen E. Trudeau ◽

Eric P. Winer ◽

Joyce Leta Steinberg ◽

Maggie Liosatos ◽

Srinivasu Poondru ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Clinical Activity ◽

Phase 2 ◽

Efficacy And Safety

Download Full-text

24 NEW PREOPERATIVE CHEMOTHERAPY WITH LYPOSOMAL ANTHRACYLINE, CISPLATIN AND METRONOMIC CAPECITABINE FOR OPERABLE AND LOCALLY ADVANCED BREAST CANCER: DATA OF EFFICACY AND SAFETY

Cancer Treatment Reviews ◽

10.1016/s0305-7372(10)70050-5 ◽

2010 ◽

Vol 36 ◽

pp. S102

Author(s):

L. Orlando ◽

P. Schiavone ◽

P. Fedele ◽

A. Nacci ◽

M. Cinefra ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Preoperative Chemotherapy ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Efficacy And Safety ◽

Breast Cancer Data ◽

Cancer Data

Download Full-text

Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study

Cancer ◽

10.1002/cncr.30170 ◽

2016 ◽

Vol 122 (20) ◽

pp. 3119-3126 ◽

Cited By ~ 8

Author(s):

Jean-Marc Ferrero ◽

Anne-Claire Hardy-Bessard ◽

Olivier Capitain ◽

Alain Lortholary ◽

Bruno Salles ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Triple Negative ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Phase 2 ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase 2 Study

Download Full-text

Abstract P2-16-08: LORHA: Efficacy and safety of 1st-line trastuzumab based treatment, administered for at least 3 years, in patients with HER2-positive metastatic or locally advanced breast cancer - Final results

10.1158/0008-5472.sabcs13-p2-16-08 ◽

2013 ◽

Author(s):

J-M Ferrero ◽

C Levy ◽

J-P Spano ◽

P Beuzeboc ◽

D Coeffic ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Efficacy And Safety ◽

Her2 Positive

Download Full-text

Abstract P3-14-16: A phase 2 trial of myocet®, cyclophosphamide +/- trastuzumab followed by weekly paclitaxel +/- trastuzumab as primary systemic therapy in operable and locally advanced breast cancer

10.1158/0008-5472.sabcs13-p3-14-16 ◽

2013 ◽

Author(s):

B Pistilli ◽

D Rossi ◽

G Benedetti ◽

AM Baldelli ◽

P Decembrini-Cognigni ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Systemic Therapy ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Phase 2 ◽

Primary Systemic Therapy ◽

Phase 2 Trial

Download Full-text

The Efficacy and Safety of Gemcitabine Plus Paclitaxel Compared to Doxorubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Journal of Cancer Prevention & Current Research ◽

10.15406/jcpcr.2015.03.00102 ◽

2015 ◽

Vol 3 (6) ◽

Author(s):

Mohammad Mohammadianpanah

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Efficacy And Safety

Download Full-text

Efficacy and safety profile of the adriamycin/cyclophosphamide (AC) followed by docetaxel/cisplatin (DC) in locally advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdx364.013 ◽

2017 ◽

Vol 28 ◽

pp. v71

Author(s):

T. Abdelhamid ◽

M. Saber ◽

A. Abdel-Samie Gaber ◽

M. Selim ◽

O. Youssef ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Safety Profile ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Efficacy And Safety

Download Full-text

Exclusive radiation therapy after neoadjuvant chemotherapy for locally advanced breast cancer: experience of a single academic institution

European Journal of Cancer ◽

10.1016/s0959-8049(02)80501-9 ◽

2002 ◽

Vol 38 (11) ◽

pp. S150

Author(s):

J Caudrelier

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Academic Institution ◽

Advanced Breast ◽

Cancer Experience

Download Full-text

Promising clinical and pathological response rates with neoadjuvant sequential doxorubicine (DOX) and docetaxel (DOC) in locally advanced breast cancer (LABC)

European Journal of Cancer ◽

10.1016/s0959-8049(02)80194-0 ◽

2002 ◽

Vol 38 (11) ◽

pp. S66

Author(s):

W Wynendaele

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Response Rates ◽

Pathological Response ◽

Advanced Breast

Download Full-text

Pilot Investigation of Ultrasound Imaging and Spectroscopy as Early Indicators of Locally- Advanced Breast Cancer Response to Neoadjuvant Treatment

Case Medical Research ◽

10.31525/ct1-nct04134780 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Ultrasound Imaging ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Breast ◽

Pilot Investigation ◽

Imaging And Spectroscopy ◽

Early Indicators

Download Full-text